nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesoridazine—HTR2A—coronary artery disease	0.338	1	CbGaD
Mesoridazine—HTR1A—Penbutolol—coronary artery disease	0.139	0.417	CbGbCtD
Mesoridazine—KCNH2—purkinje fiber—coronary artery disease	0.0372	0.357	CbGeAlD
Mesoridazine—CYP2D6—Niacin—coronary artery disease	0.0335	0.101	CbGbCtD
Mesoridazine—CYP2D6—Timolol—coronary artery disease	0.0311	0.0935	CbGbCtD
Mesoridazine—CYP2D6—Captopril—coronary artery disease	0.0274	0.0824	CbGbCtD
Mesoridazine—CYP2D6—Simvastatin—coronary artery disease	0.0265	0.0795	CbGbCtD
Mesoridazine—CYP2D6—Lovastatin—coronary artery disease	0.0259	0.0778	CbGbCtD
Mesoridazine—CYP2D6—Pravastatin—coronary artery disease	0.0259	0.0778	CbGbCtD
Mesoridazine—CYP2D6—Atorvastatin—coronary artery disease	0.0236	0.0709	CbGbCtD
Mesoridazine—KCNH2—endocardium—coronary artery disease	0.0192	0.184	CbGeAlD
Mesoridazine—HTR2A—arteriole—coronary artery disease	0.00793	0.076	CbGeAlD
Mesoridazine—HTR2A—pulmonary artery—coronary artery disease	0.0052	0.0498	CbGeAlD
Mesoridazine—HTR2A—sympathetic nervous system—coronary artery disease	0.00506	0.0484	CbGeAlD
Mesoridazine—HTR2A—vagus nerve—coronary artery disease	0.0049	0.0469	CbGeAlD
Mesoridazine—HTR2A—vein—coronary artery disease	0.00473	0.0453	CbGeAlD
Mesoridazine—HTR2A—autonomic nervous system—coronary artery disease	0.0034	0.0325	CbGeAlD
Mesoridazine—HTR2A—artery—coronary artery disease	0.00193	0.0184	CbGeAlD
Mesoridazine—HTR2A—endothelium—coronary artery disease	0.00163	0.0156	CbGeAlD
Mesoridazine—KCNH2—cardiac ventricle—coronary artery disease	0.00161	0.0155	CbGeAlD
Mesoridazine—KCNH2—myocardium—coronary artery disease	0.00152	0.0145	CbGeAlD
Mesoridazine—CHRM2—heart—coronary artery disease	0.00147	0.0141	CbGeAlD
Mesoridazine—CHRM2—cardiovascular system—coronary artery disease	0.00138	0.0133	CbGeAlD
Mesoridazine—HTR1A—cardiovascular system—coronary artery disease	0.00112	0.0108	CbGeAlD
Mesoridazine—KCNH2—heart—coronary artery disease	0.00106	0.0102	CbGeAlD
Mesoridazine—KCNH2—cardiovascular system—coronary artery disease	0.001	0.00958	CbGeAlD
Mesoridazine—KCNH2—cardiac atrium—coronary artery disease	0.000907	0.00868	CbGeAlD
Mesoridazine—KCNH2—blood—coronary artery disease	0.000791	0.00757	CbGeAlD
Mesoridazine—HTR2A—heart—coronary artery disease	0.00071	0.00679	CbGeAlD
Mesoridazine—HTR2A—cardiovascular system—coronary artery disease	0.00067	0.00641	CbGeAlD
Mesoridazine—HTR2A—blood—coronary artery disease	0.00053	0.00507	CbGeAlD
Mesoridazine—CYP2D6—blood—coronary artery disease	0.000482	0.00462	CbGeAlD
Mesoridazine—Eletriptan—HTR7—coronary artery disease	0.00048	0.107	CrCbGaD
Mesoridazine—Eletriptan—CYP2C19—coronary artery disease	0.000298	0.0661	CrCbGaD
Mesoridazine—Cyamemazine—HTR2A—coronary artery disease	0.000263	0.0585	CrCbGaD
Mesoridazine—Thioridazine—HTR7—coronary artery disease	0.000241	0.0535	CrCbGaD
Mesoridazine—Perphenazine—HTR7—coronary artery disease	0.000221	0.0491	CrCbGaD
Mesoridazine—Pipotiazine—CYP2C19—coronary artery disease	0.000201	0.0446	CrCbGaD
Mesoridazine—Chlorpromazine—HTR7—coronary artery disease	0.000175	0.039	CrCbGaD
Mesoridazine—Acepromazine—HTR2A—coronary artery disease	0.000169	0.0376	CrCbGaD
Mesoridazine—Thioproperazine—HTR2A—coronary artery disease	0.000165	0.0367	CrCbGaD
Mesoridazine—Pipotiazine—HTR2A—coronary artery disease	0.000163	0.0362	CrCbGaD
Mesoridazine—Thiothixene—HTR2A—coronary artery disease	0.000163	0.0362	CrCbGaD
Mesoridazine—Thioridazine—CYP2C19—coronary artery disease	0.000149	0.0332	CrCbGaD
Mesoridazine—Fluphenazine—HTR2A—coronary artery disease	0.000141	0.0312	CrCbGaD
Mesoridazine—Perphenazine—CYP2C19—coronary artery disease	0.000137	0.0305	CrCbGaD
Mesoridazine—Propiomazine—HTR2A—coronary artery disease	0.000135	0.0301	CrCbGaD
Mesoridazine—Promazine—CYP2C19—coronary artery disease	0.000124	0.0275	CrCbGaD
Mesoridazine—Thioridazine—HTR2A—coronary artery disease	0.000121	0.0269	CrCbGaD
Mesoridazine—Acepromazine—ALB—coronary artery disease	0.000116	0.0257	CrCbGaD
Mesoridazine—Methotrimeprazine—HTR2A—coronary artery disease	0.000116	0.0257	CrCbGaD
Mesoridazine—Promethazine—HTR2A—coronary artery disease	0.000114	0.0253	CrCbGaD
Mesoridazine—Thioproperazine—ALB—coronary artery disease	0.000113	0.0251	CrCbGaD
Mesoridazine—Trifluoperazine—HTR2A—coronary artery disease	0.000112	0.025	CrCbGaD
Mesoridazine—Thiothixene—ALB—coronary artery disease	0.000111	0.0247	CrCbGaD
Mesoridazine—Pipotiazine—ALB—coronary artery disease	0.000111	0.0247	CrCbGaD
Mesoridazine—Perphenazine—HTR2A—coronary artery disease	0.000111	0.0247	CrCbGaD
Mesoridazine—Promazine—HTR2A—coronary artery disease	0.0001	0.0223	CrCbGaD
Mesoridazine—Chlorpromazine—HTR2A—coronary artery disease	8.82e-05	0.0196	CrCbGaD
Mesoridazine—Chlorpromazine—ALB—coronary artery disease	6.04e-05	0.0134	CrCbGaD
Mesoridazine—DRD3—Signaling Pathways—FGF2—coronary artery disease	7.14e-06	3.24e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	7.12e-06	3.23e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—APOA1—coronary artery disease	7.11e-06	3.22e-05	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—AKT1—coronary artery disease	7.1e-06	3.22e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—GSK3B—coronary artery disease	7.09e-06	3.22e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AGT—coronary artery disease	7.09e-06	3.21e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—LEP—coronary artery disease	7.08e-06	3.21e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—APOE—coronary artery disease	7.08e-06	3.21e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—LEP—coronary artery disease	7.06e-06	3.2e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—APOE—coronary artery disease	7.06e-06	3.2e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—GSK3B—coronary artery disease	7.06e-06	3.2e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—KDR—coronary artery disease	7.05e-06	3.19e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—NOS3—coronary artery disease	7.04e-06	3.19e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CASP3—coronary artery disease	7.04e-06	3.19e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—POMC—coronary artery disease	7.04e-06	3.19e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CREB1—coronary artery disease	7.04e-06	3.19e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—POMC—coronary artery disease	7e-06	3.17e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CREB1—coronary artery disease	7e-06	3.17e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MAPK14—coronary artery disease	7e-06	3.17e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—APOA1—coronary artery disease	7e-06	3.17e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—IL6—coronary artery disease	6.99e-06	3.17e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—APOA1—coronary artery disease	6.98e-06	3.16e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—LEP—coronary artery disease	6.95e-06	3.15e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—APOE—coronary artery disease	6.95e-06	3.15e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—KDR—coronary artery disease	6.93e-06	3.14e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—KDR—coronary artery disease	6.92e-06	3.14e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MAPK14—coronary artery disease	6.89e-06	3.12e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CCL2—coronary artery disease	6.89e-06	3.12e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MAPK14—coronary artery disease	6.87e-06	3.12e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—APOA1—coronary artery disease	6.87e-06	3.11e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—ESR1—coronary artery disease	6.87e-06	3.11e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IL6R—coronary artery disease	6.87e-06	3.11e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CCND1—coronary artery disease	6.85e-06	3.11e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CCL2—coronary artery disease	6.85e-06	3.11e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—JAK2—coronary artery disease	6.84e-06	3.1e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IL6R—coronary artery disease	6.83e-06	3.1e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—KDR—coronary artery disease	6.81e-06	3.09e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—F2—coronary artery disease	6.78e-06	3.07e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—FN1—coronary artery disease	6.78e-06	3.07e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IGF1—coronary artery disease	6.77e-06	3.07e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	6.76e-06	3.07e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—ESR1—coronary artery disease	6.76e-06	3.06e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IL6ST—coronary artery disease	6.76e-06	3.06e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—ESR1—coronary artery disease	6.74e-06	3.06e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—MAPK1—coronary artery disease	6.74e-06	3.05e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IGF1—coronary artery disease	6.73e-06	3.05e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—PIK3CA—coronary artery disease	6.71e-06	3.04e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—NFKBIA—coronary artery disease	6.7e-06	3.04e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—MAPK1—coronary artery disease	6.7e-06	3.04e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—F2—coronary artery disease	6.67e-06	3.03e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—FN1—coronary artery disease	6.67e-06	3.03e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—F2—coronary artery disease	6.66e-06	3.02e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—FN1—coronary artery disease	6.66e-06	3.02e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MMP9—coronary artery disease	6.65e-06	3.02e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IL6ST—coronary artery disease	6.65e-06	3.01e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GSTP1—coronary artery disease	6.64e-06	3.01e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—ESR1—coronary artery disease	6.63e-06	3.01e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IL6ST—coronary artery disease	6.63e-06	3.01e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—NFKBIA—coronary artery disease	6.6e-06	2.99e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—NFKBIA—coronary artery disease	6.58e-06	2.98e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	6.58e-06	2.98e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—F2—coronary artery disease	6.55e-06	2.97e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—FN1—coronary artery disease	6.55e-06	2.97e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—HMOX1—coronary artery disease	6.55e-06	2.97e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	6.53e-06	2.96e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—KIT—coronary artery disease	6.49e-06	2.94e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	6.48e-06	2.94e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CAT—coronary artery disease	6.46e-06	2.93e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—AKT1—coronary artery disease	6.45e-06	2.92e-05	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—PIK3CA—coronary artery disease	6.44e-06	2.92e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—SERPINE1—coronary artery disease	6.43e-06	2.91e-05	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—PIK3CA—coronary artery disease	6.4e-06	2.9e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—SERPINE1—coronary artery disease	6.4e-06	2.9e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—KIT—coronary artery disease	6.39e-06	2.9e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—KIT—coronary artery disease	6.37e-06	2.89e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—KIT—coronary artery disease	6.27e-06	2.84e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—APOB—coronary artery disease	6.27e-06	2.84e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CXCL8—coronary artery disease	6.25e-06	2.83e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—GSK3B—coronary artery disease	6.23e-06	2.82e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—FGF2—coronary artery disease	6.22e-06	2.82e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—FGF2—coronary artery disease	6.19e-06	2.81e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—POMC—coronary artery disease	6.18e-06	2.8e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CREB1—coronary artery disease	6.18e-06	2.8e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—NOS3—coronary artery disease	6.14e-06	2.78e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—GSK3B—coronary artery disease	6.13e-06	2.78e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—GSK3B—coronary artery disease	6.12e-06	2.77e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—NOS3—coronary artery disease	6.11e-06	2.77e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GSTM1—coronary artery disease	6.1e-06	2.76e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—POMC—coronary artery disease	6.08e-06	2.76e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CREB1—coronary artery disease	6.08e-06	2.76e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—POMC—coronary artery disease	6.07e-06	2.75e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CREB1—coronary artery disease	6.07e-06	2.75e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCL2—coronary artery disease	6.05e-06	2.74e-05	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—AKT1—coronary artery disease	6.03e-06	2.74e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IL6R—coronary artery disease	6.03e-06	2.73e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	6.02e-06	2.73e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—LPL—coronary artery disease	5.99e-06	2.71e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CASP3—coronary artery disease	5.98e-06	2.71e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—VEGFA—coronary artery disease	5.97e-06	2.71e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—POMC—coronary artery disease	5.97e-06	2.71e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CREB1—coronary artery disease	5.97e-06	2.71e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—JAK2—coronary artery disease	5.97e-06	2.7e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCL2—coronary artery disease	5.95e-06	2.7e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IGF1—coronary artery disease	5.94e-06	2.69e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—IL6—coronary artery disease	5.94e-06	2.69e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCL2—coronary artery disease	5.94e-06	2.69e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—JAK2—coronary artery disease	5.93e-06	2.69e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IL6R—coronary artery disease	5.93e-06	2.69e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IL6R—coronary artery disease	5.92e-06	2.68e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—MAPK1—coronary artery disease	5.92e-06	2.68e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IGF1—coronary artery disease	5.85e-06	2.65e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—PIK3CA—coronary artery disease	5.85e-06	2.65e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCL2—coronary artery disease	5.84e-06	2.65e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GPX1—coronary artery disease	5.84e-06	2.65e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IGF1—coronary artery disease	5.84e-06	2.65e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IL6R—coronary artery disease	5.82e-06	2.64e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	5.82e-06	2.64e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CCND1—coronary artery disease	5.82e-06	2.64e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—PIK3CA—coronary artery disease	5.82e-06	2.64e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—MAPK1—coronary artery disease	5.81e-06	2.63e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IGF1—coronary artery disease	5.74e-06	2.6e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	5.71e-06	2.59e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CD36—coronary artery disease	5.69e-06	2.58e-05	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	5.65e-06	2.56e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MMP9—coronary artery disease	5.65e-06	2.56e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	5.64e-06	2.56e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	5.62e-06	2.55e-05	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	5.56e-06	2.52e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	5.55e-06	2.52e-05	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	5.55e-06	2.52e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	5.54e-06	2.51e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TGFB1—coronary artery disease	5.48e-06	2.49e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—AKT1—coronary artery disease	5.48e-06	2.48e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—FGF2—coronary artery disease	5.46e-06	2.48e-05	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	5.46e-06	2.48e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	5.45e-06	2.47e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	5.44e-06	2.47e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CXCL8—coronary artery disease	5.42e-06	2.46e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—MTHFR—coronary artery disease	5.39e-06	2.44e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—NOS3—coronary artery disease	5.39e-06	2.44e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MAPK1—coronary artery disease	5.38e-06	2.44e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—FGF2—coronary artery disease	5.38e-06	2.44e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—FGF2—coronary artery disease	5.36e-06	2.43e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—NOS3—coronary artery disease	5.3e-06	2.4e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—NOS3—coronary artery disease	5.29e-06	2.4e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—FGF2—coronary artery disease	5.28e-06	2.39e-05	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	5.26e-06	2.38e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—JAK2—coronary artery disease	5.24e-06	2.37e-05	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	5.23e-06	2.37e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CASP3—coronary artery disease	5.21e-06	2.36e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—NOS3—coronary artery disease	5.21e-06	2.36e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CASP3—coronary artery disease	5.18e-06	2.35e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—IL6—coronary artery disease	5.18e-06	2.35e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—JAK2—coronary artery disease	5.15e-06	2.34e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—IL6—coronary artery disease	5.15e-06	2.33e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—JAK2—coronary artery disease	5.14e-06	2.33e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	5.13e-06	2.33e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—AGT—coronary artery disease	5.12e-06	2.32e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—VEGFA—coronary artery disease	5.07e-06	2.3e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CCND1—coronary artery disease	5.07e-06	2.3e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—JAK2—coronary artery disease	5.06e-06	2.29e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	5.05e-06	2.29e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CCND1—coronary artery disease	5.05e-06	2.29e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	5.04e-06	2.28e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—APOE—coronary artery disease	5.02e-06	2.27e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—APOA1—coronary artery disease	4.96e-06	2.25e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	4.96e-06	2.25e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MMP9—coronary artery disease	4.92e-06	2.23e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MMP9—coronary artery disease	4.9e-06	2.22e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CXCL8—coronary artery disease	4.78e-06	2.17e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	4.78e-06	2.16e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	4.75e-06	2.15e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	4.7e-06	2.13e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	4.69e-06	2.13e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—PIK3CA—coronary artery disease	4.67e-06	2.11e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TGFB1—coronary artery disease	4.66e-06	2.11e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	4.62e-06	2.09e-05	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	4.62e-06	2.09e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CASP3—coronary artery disease	4.58e-06	2.07e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MAPK1—coronary artery disease	4.57e-06	2.07e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—IL6—coronary artery disease	4.55e-06	2.06e-05	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	4.54e-06	2.06e-05	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	4.53e-06	2.06e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CASP3—coronary artery disease	4.5e-06	2.04e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CASP3—coronary artery disease	4.49e-06	2.04e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—IL6—coronary artery disease	4.47e-06	2.03e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—IL6—coronary artery disease	4.46e-06	2.02e-05	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	4.46e-06	2.02e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCND1—coronary artery disease	4.45e-06	2.02e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	4.42e-06	2e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CASP3—coronary artery disease	4.42e-06	2e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	4.4e-06	1.99e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—IL6—coronary artery disease	4.39e-06	1.99e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCND1—coronary artery disease	4.38e-06	1.99e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCND1—coronary artery disease	4.37e-06	1.98e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PPARG—coronary artery disease	4.37e-06	1.98e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MMP9—coronary artery disease	4.32e-06	1.96e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—POMC—coronary artery disease	4.31e-06	1.95e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCND1—coronary artery disease	4.3e-06	1.95e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MMP9—coronary artery disease	4.25e-06	1.93e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MMP9—coronary artery disease	4.24e-06	1.92e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—AKT1—coronary artery disease	4.19e-06	1.9e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MMP9—coronary artery disease	4.18e-06	1.89e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IL6—coronary artery disease	4.13e-06	1.87e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	4.13e-06	1.87e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	4.12e-06	1.87e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	4.06e-06	1.84e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	4.05e-06	1.84e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	4.04e-06	1.83e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	3.98e-06	1.8e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—PIK3CA—coronary artery disease	3.96e-06	1.8e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	3.96e-06	1.79e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—ALB—coronary artery disease	3.93e-06	1.78e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—VEGFA—coronary artery disease	3.88e-06	1.76e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	3.82e-06	1.73e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	3.81e-06	1.73e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—AKT1—coronary artery disease	3.81e-06	1.73e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—NOS3—coronary artery disease	3.76e-06	1.7e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	3.75e-06	1.7e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TGFB1—coronary artery disease	3.56e-06	1.62e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IL6—coronary artery disease	3.51e-06	1.59e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	3.51e-06	1.59e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	3.5e-06	1.59e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MAPK1—coronary artery disease	3.49e-06	1.58e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	3.45e-06	1.57e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	3.44e-06	1.56e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	3.44e-06	1.56e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PTGS2—coronary artery disease	3.44e-06	1.56e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	3.44e-06	1.56e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	3.43e-06	1.56e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	3.38e-06	1.53e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—AKT1—coronary artery disease	3.24e-06	1.47e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IL6—coronary artery disease	3.06e-06	1.39e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IL6—coronary artery disease	3.04e-06	1.38e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	3.03e-06	1.37e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	2.98e-06	1.35e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	2.98e-06	1.35e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	2.93e-06	1.33e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—AKT1—coronary artery disease	2.82e-06	1.28e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—AKT1—coronary artery disease	2.81e-06	1.27e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IL6—coronary artery disease	2.69e-06	1.22e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IL6—coronary artery disease	2.64e-06	1.2e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IL6—coronary artery disease	2.64e-06	1.19e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IL6—coronary artery disease	2.59e-06	1.18e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—AKT1—coronary artery disease	2.48e-06	1.12e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—AKT1—coronary artery disease	2.44e-06	1.1e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—AKT1—coronary artery disease	2.43e-06	1.1e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AKT1—coronary artery disease	2.39e-06	1.08e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	2.12e-06	9.59e-06	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—AKT1—coronary artery disease	1.73e-06	7.83e-06	CbGpPWpGaD
